TRTRIAN FUND MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q2 2026

Top Holdings8 positions

Checking export access…
Activity:

GE AEROSPACE

4M$1.5B35.6%$62.66+392.58%
20 qtrssince 2021-Q3
Unchanged
0
JHGJHGDelisted

JANUS HENDERSON GROUP PLC

25.7M$1.3B31.5%$33.84+53.51%
19 qtrssince 2021-Q4
Decreased
0

SOLVENTUM CORP

8.2M$635.5M15.0%$58.48+45.89%
9 qtrssince 2024-Q2
Unchanged
0
1.1M$257.8M6.1%——
22 qtrssince 2021-Q1
Unchanged
0

WENDYS CO

30.5M$252.6M6.0%$15.93-60.40%
28 qtrssince 2019-Q3
Increased
63

GE HEALTHCARE TECHNOLOGIES I

3.1M$197.5M4.7%$64.00+5.85%
14 qtrssince 2023-Q1
Increased
93

INVESCO LTD

1.6M$42.9M1.0%$11.92+145.50%
25 qtrssince 2020-Q2
Decreased
0

MAGNUM ICE CREAM CO NV

241,042$4.2M0.1%$14.95+19.26%
2 qtrssince 2026-Q1
Unchanged
0
$4.2B
AUM
8
Positions
Q2 2026
Filing
HI score · 3.5/5
Quarterly 13F Value Change
-4%Q1'25$3.7B+2%Q2'25$3.8B+8%Q3'25$4.1B-3%Q4'25$4B-3%Q1'26$3.9B+10%Q2'26$4.2B
Activity profile
$ moved · Q2'26
New0%Increased42%Decreased58%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.3 years
<1Q0%1-4Q13%1-2Y0%2Y+88%

TRIAN FUND MANAGEMENT, L.P. manages $4.2B across 8 positions as of Q2 2026. Top holdings: GE (35.6%), JHG (31.5%), SOLV (15.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3.5/5.0.

Q2 2026 Summary

Increased 2, trimmed 2. Top move: GEHC (INCREASED, conviction 93). Portfolio: $4.2B across 8 positions.

Top holdings by portfolio weight

Total AUM$4B
GE35.61%
JHG31.53%
SOLV15.02%
FERGL6.09%
WEN5.97%
GEHC4.67%
IVZ1.01%
MICC0.10%

Portfolio allocation by GICS sector

Sectors6
Industrials35.61%
Financial Services32.54%
Healthcare19.69%
Unknown6.09%
Consumer Cyclical5.97%
Consumer Defensive0.10%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Industrials, Financial Services, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(3.5 / 5.0)
Holdings P&L79
Conviction44
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
WENWENWENDYS CO
Q2 2025 → Q2 2026+44,751 shares-$192.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used